Is cancer outwitting personalized medicine?

A few days ago I read a fascinating article titled “Is cancer outwitting personalized medicine?” It’s a “must-read”: And then this morning I watched a short “Patient Power” video (February 21, 2012) on personalized treatment, side effects, myeloma heterogeneity and patient subgroups, cytogenetic abnormalities, high-risk disease, possibility of high risk genes/features, gene expression profiling on […]